Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Artificial Urinary Sphincter Placement Workup

  • Author: Kamran P Sajadi, MD; Chief Editor: Edward David Kim, MD, FACS  more...
 
Updated: May 16, 2016
 

Laboratory Studies

See the list below:

  • Urinalysis and urine culture: The possibility of UTI should be ruled out before implanting an artificial urinary sphincter. The presence of a UTI is a contraindication to artificial urinary sphincter placement.
  • Serum white blood cell (WBC) count: Systemic leukocytosis should be treated before surgery.
  • Serum creatinine: The patient should have relatively normal and stable renal function before AMS 800 artificial urinary sphincter placement.
Next

Imaging Studies

See the list below:

  • Voiding cystourethrography
    • This test is optional but can be used to assess bladder neck and urethral function (ie, internal, external sphincter) during the filling and voiding phases.
    • Voiding cystourethrography (VCUG) allows radiographic observation of an incompetent bladder neck and coincident leakage during Valsalva maneuvers. VCUG is performed most often at the time of videourodynamics.
    • Grade 2 or higher vesicoureteral reflux on VCUG should be corrected before placement of the artificial urinary sphincter because the sphincter can exacerbate reflux.
Previous
Next

Other Tests

See the list below:

  • Voiding diary: A voiding diary is a daily record of a patient's bladder activity. The diary is an objective documentation of a patient's voiding pattern, incontinent episodes, and any inciting events associated with urinary incontinence. Although not critical, a properly logged voiding diary can provide stronger documentation of the degree of incontinence than the standard question regarding number of pads per day used by the patient. Keeping track of fluid intake and urine output in the diary can give further insight into the patient's incontinence and identify patients who can improve their incontinence with less invasive interventions, such as timed voiding. It can also help identify patients with associated problems such as polyuria.
  • Physical examination: All patients with incontinence should undergo a complete physical examination. Women with incontinence must undergo a full pelvic examination to note pelvic floor weakness (eg, cystocele, rectocele, enterocele), urethral hypermobility, urethral or vaginal lesions, or uterine or adnexal masses.
  • Pad test: Patients with classic intrinsic sphincteric dysfunction present to the office with a diaper or a pad in place. An adult male with a damp or wet pad inside his underwear has urinary incontinence unless proven otherwise. It is important to ask patients not only how many pads they use in a day but also how wet those pads get (from lightly dampened to soaked).
  • Standing cough stress test: The patient stands upright with feet shoulder width apart. Place a large towel under the patient's feet or a small trash can between the patient's feet to catch the flow of urine. Instruct the patient to perform the Valsalva maneuver and to cough in gradients (ie, mild, moderate, severe). Observable urine leakage in this position constitutes a positive test result. If the bladder is empty at the time of the Valsalva maneuver or cough, the test result is falsely negative. An excellent alternative is to leave the bladder full following cystoscopy and have the patient stand over a towel. Ask the patient to perform the Valsalva maneuver, and watch for a leak. Following this task, see if the patient can maintain continence while walking to the restroom.
  • Urodynamic studies
    • Urodynamics is a means of evaluating the bladder capacity, compliance, abdominal leak point pressure, presence of phasic contractions, and pressure-flow relationship between the bladder and the urethra.
    • Simple urodynamics involves noninvasive uroflow, postvoid residual (PVR) urine volume, and single-channel cystometrography (CMG). A single-channel CMG (simple CMG) is used to assess the first sensation of filling, fullness, and urge. Bladder compliance and the presence of uninhibited detrusor contractions (eg, phasic contractions) can be noted during this filling CMG.
      • A filling CMG is used to assess the bladder capacity, compliance, and presence of phasic contractions.
      • Most commonly, liquid filling medium is used.
      • An average adult bladder holds approximately 450-500 mL of urine.
      • During the test, provocative maneuvers, such as coughing, handwashing, sitting on the commode for 1 full minute, and heel jouncing, may help unveil bladder instability.
      • Insert a catheter (connected to a special computer) into the bladder for a single-channel CMG. Information recorded by the computer is interpreted.
      • Eyeball cystometry does not require special computers. Perform bedside cystometry by inserting a catheter into the bladder, hanging the irrigant bag at a predetermined height (eg, 100 cm water), and observing the fluctuation of the meniscus within the water chamber during uninhibited detrusor contractions. Eyeball cystometry can also be performed with a flexible cystoscope being used as the connection tubing, allowing simultaneous cystoscopy.
    • Multichannel urodynamic studies are more complex than simple urodynamic studies and can be used to obtain additional information, including a noninvasive uroflow, PVR, filling CMG, abdominal or Valsalva leak point pressure (ALPP or VLPP), voiding CMG (pressure-flow study), and electromyography (EMG). Water is the fluid medium used for multichannel urodynamics.
      • A voiding CMG (pressure-flow study) simultaneously records the voiding detrusor pressure and the rate of urinary flow. This is the only test that can be used to assess bladder contractility and the extent of a bladder outlet obstruction. Pressure-flow studies can be combined with a voiding CMG and videourodynamic study for complicated cases of incontinence. Note that most adult men normally void with detrusor pressures (PdetQmax) of 40-80 cm water. However, pressures of 20-30 cm water or lower are considered to be within the reference range if uroflow (Qmax) is within the reference range or high.
      • Abdominal (Valsalva) leak point pressure (ALPP) measurements allow clinicians to classify stress urinary incontinence into type I, type II, and type III, or type II and III in combination. ALPP of 0-60 cm water is classified as type III stress urinary incontinence (ie, intrinsic sphincteric dysfunction). In short, the outlet is so weak that even low pressures can overcome the resistance and produce incontinence. ALPP of 60-90 cm water is classified as type II/III stress urinary incontinence (ie, combination of urethral hypermobility and intrinsic sphincteric dysfunction). ALPP of 90-120 cm water is classified as type II stress urinary incontinence (ie, urethral hypermobility). ALPP greater than 120 cm water is classified as type I stress urinary incontinence.
      • ALPP should be measured when the bladder is half full (eg, 250 mL), and both the Valsalva and coughing maneuvers should be performed. Initially, instruct the patient to bear down in gradients (ie, mild, moderate, severe) and then note the ALPP as the lowest intravesical pressure (Pves) at which leakage is observed.
      • If Valsalva maneuvers fail to produce the desired response, instruct the patient to cough in gradients (ie, mild, moderate, severe) to obtain the ALPP. The lowest intravesical pressure (Pves) at which leakage is observed is the ALPP. The ALPP obtained with the Valsalva maneuver is more accurate than the cough-induced ALPP. However, both techniques should be used if Valsalva maneuvers fail to manifest stress urinary incontinence.
      • Alternatively, both Valsalva and cough-induced ALPP may be repeated by increasing the bladder volume in 100-mL gradients. Increasing the bladder volume reportedly increases the sensitivity of detecting ALPP.
      • Obtaining ALPP in male stress incontinence (ISD) is optional because men with type III stress incontinence, by definition, have ALPP less than 60 cm water.
    • The most sophisticated study is videourodynamics, which is the leading standard in the evaluation of a patient with incontinence. In this study, the following are obtained: noninvasive uroflow, PVR, filling CMG, ALPP, voiding CMG (pressure-flow), EMG, static cystography, and VCUG. The fluid medium used for videourodynamics is radiographic contrast.
    • Performing urodynamic studies
      • Instruct the patient to arrive at the urodynamic laboratory with a relatively full bladder. Note that patients with ISD have a low-volume or empty bladder because of continuous incontinence. Perform a noninvasive uroflow and PVR.
      • Some physicians perform cystoscopy at the same time as urodynamics, although the two can be done separately. Place a urodynamic urethral catheter, rectal tube, and EMG electrodes.
      • Rotate the patient to a standing or sitting position and equalize transducers. Commence bladder filling using room-temperature water or contrast (Conray). Cold water may evoke false-positive detrusor contractions (phasic contractions). Fill the bladder at a medium rate (eg, 50 mL/min). Assess the first sensation of filling, fullness, and urge. Note bladder compliance and mark the presence of uninhibited detrusor contractions.
      • When the bladder fills to 250 mL, measure the ALPP. Instruct the patient to perform the Valsalva maneuver in gradients (ie, mild, moderate, severe) followed by cough (ie, mild, moderate, severe). Observe the urine leakage fluoroscopically and by direct inspection.
      • Following the ALPP measurements, finish the filling CMG to completion. When the patient has a strong desire to void, perform a voiding CMG (pressure-flow study). At this point, note urodynamic parameters, such as maximal flow rate (Qmax) and detrusor pressure at maximal flow rate (PdetQmax).
      • During the voiding CMG, note the activity of the EMG electrodes and VCUG for possible detrusor sphincter dyssynergia (DSD). The presence of DSD is confirmed by increases in EMG activity during detrusor contraction or closure of the external sphincter on VCUG during voiding.
      • After the patient voids to completion, the videourodynamic study is complete. The patient is informed about the findings on urodynamic studies and is sent home.
    • Uroflow rate: The uroflow rate is a screening test used mainly to evaluate bladder outlet obstruction. The uroflow rate is the volume of urine voided per unit of time. Maximal flow rate (Qmax) greater than 15 mL/s may be considered within the reference range. Low uroflow rates (< 15 mL/s) may reflect urethral obstruction, a weak detrusor, or both. This test alone cannot be used to distinguish between obstruction and a poorly functioning detrusor. Patients with intrinsic sphincteric dysfunction demonstrate uroflow rates within the reference range. A voided volume of 150 mL is a generally accepted minimum for accurate uroflowmetry, and variations of 2-4 mL/s in a single patient are common, so more than one measurement may be required. A maximum flow rate of less than 15 mL/s is usually considered abnormal but must be considered within the context of the patient's clinical presentation.
    • Postvoid residual urine volume: This measurement is a part of the basic evaluation for urinary incontinence. Healthy men usually have a PVR urine volume of less than 100 mL. If the PVR volume is high, the bladder may be atonic or the bladder outlet may be obstructed. Both of these conditions cause urinary retention and overflow incontinence. Patients with intrinsic sphincteric dysfunction have minimal PVR urine volume.
    • Electromyography: EMG helps ascertain the presence of coordinated or uncoordinated voiding. Failure of urethral relaxation during a bladder contraction results in uncoordinated voiding (ie, DSD). EMG is not necessary for evaluation of men who are incontinent after prostatectomy; however, EMG is used in combination with multichannel urodynamic studies and is important in the evaluation of neurogenic bladders.
  • Cystoscopy
    • Cystoscopy is optional in female patients. However, it may uncover bladder lesions (eg, stitch in the bladder, bladder cancer, bladder stone, vesicovaginal fistula) that, although uncommon, would remain undiagnosed based on urodynamics findings alone. The bladder can be left full following cystoscopy to perform the standing cough test.
    • In male urinary incontinence, cystoscopy should be performed more routinely, because a visual inspection of the urethra helps establish the presence of urethral stricture or diverticulum, bladder neck contracture or anastomotic stricture, or gross evidence of poor urethral coaptation and closure. It is important to examine the external sphincter both with and without the flow of irrigant to ascertain the degree of sphincter incompetence.
    • In general, cystoscopy is also indicated for patients reporting persistent dysuria, storage symptoms, or hematuria. Obvious causes of bladder overactivity, including cystitis, stone, and tumor, can be easily diagnosed. Patients with a history of pelvic radiation may have findings of radiation cystitis on cystoscopy. This information is important in determining the etiology of the incontinence and may influence treatment decisions.
  • In the absence of videourodynamics, the clinician may obtain adequate information regarding male incontinence from (1) noninvasive uroflow and PVR and (2) simple cystometry in combination with cystoscopy.
Previous
 
 
Contributor Information and Disclosures
Author

Kamran P Sajadi, MD Assistant Professor, Urology, Oregon Health & Science University

Kamran P Sajadi, MD is a member of the following medical societies: American Urological Association, Endourological Society, Oregon Medical Association, Western Section of the American Urological Association, American Urogynecologic Society, Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction

Disclosure: Nothing to disclose.

Coauthor(s)

Martha K Terris, MD, FACS Professor, Department of Surgery, Section of Urology, Director, Urology Residency Training Program, Medical College of Georgia; Professor, Department of Physician Assistants, Medical College of Georgia School of Allied Health; Chief, Section of Urology, Augusta Veterans Affairs Medical Center

Martha K Terris, MD, FACS is a member of the following medical societies: American Cancer Society, Association of Women Surgeons, American Society of Clinical Oncology, Society of Urology Chairpersons and Program Directors, Society of Women in Urology, Society of Government Service Urologists, American College of Surgeons, American Institute of Ultrasound in Medicine, American Urological Association, New York Academy of Sciences, Society of University Urologists

Disclosure: Nothing to disclose.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Shlomo Raz, MD Professor, Department of Surgery, Division of Urology, University of California, Los Angeles, David Geffen School of Medicine

Shlomo Raz, MD is a member of the following medical societies: American College of Surgeons, American Medical Association, American Urological Association, California Medical Association

Disclosure: Nothing to disclose.

Chief Editor

Edward David Kim, MD, FACS Professor of Surgery, Division of Urology, University of Tennessee Graduate School of Medicine; Consulting Staff, University of Tennessee Medical Center

Edward David Kim, MD, FACS is a member of the following medical societies: American College of Surgeons, Tennessee Medical Association, Sexual Medicine Society of North America, American Society for Reproductive Medicine, American Society of Andrology, American Urological Association

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Repros.

Additional Contributors

Edward David Kim, MD, FACS Professor of Surgery, Division of Urology, University of Tennessee Graduate School of Medicine; Consulting Staff, University of Tennessee Medical Center

Edward David Kim, MD, FACS is a member of the following medical societies: American College of Surgeons, Tennessee Medical Association, Sexual Medicine Society of North America, American Society for Reproductive Medicine, American Society of Andrology, American Urological Association

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Repros.

Acknowledgements

The authors and editors of Medscape Reference gratefully acknowledge the contributions of previous author, Jong M. Choe, MD, FACS, to the development and writing of this article.

References
  1. Ziegelmann MJ, Linder BJ, Rivera ME, Viers BR, Rangel LJ, Elliott DS. Outcomes of artificial urinary sphincter placement in octogenarians. Int J Urol. 2016 May. 23 (5):419-23. [Medline].

  2. Lai HH, Boone TB. Implantation of artificial urinary sphincter in patients with post-prostatectomy incontinence, and preoperative overactive bladder and mixed symptoms. J Urol. 2011 Jun. 185(6):2254-9. [Medline].

  3. Rapp DE, Reynolds WS, Lucioni A, Bales GT. Surgical technique using AdVance sling placement in the treatment of post-prostatectomy urinary incontinence. Int Braz J Urol. 2007. 33:231 - 5. [Medline].

  4. Stoffel JT, Barrett DM. The artificial genitourinary sphincter. BJU Int. 2008 Aug 5. 102(5):644-58. [Medline].

  5. Magera JS Jr, Inman BA, Elliott DS. Does preoperative topical antimicrobial scrub reduce positive surgical site culture rates in men undergoing artificial urinary sphincter placement?. J Urol. 2007 Oct. 178(4 Pt 1):1328-32; discussion 1332. [Medline].

  6. Yeung LL, Grewal S, Bullock A, Lai HH, Brandes SB. A comparison of chlorhexidine-alcohol versus povidone-iodine for eliminating skin flora before genitourinary prosthetic surgery: a randomized controlled trial. J Urol. 2013 Jan. 189(1):136-40. [Medline].

  7. Wilson SK, Delk JR 2nd. Ectopic placement of AMS 800 urinary control system pressure-regulating balloon. Urology. 2005 Jan. 65(1):167-70. [Medline].

  8. Sotelo TM, Westney OL. Outcomes related to placing an artificial urinary sphincter using a single-incision, transverse-scrotal technique in high-risk patients. BJU Int. 2008 May. 101(9):1124-7. [Medline].

  9. Henry GD, Graham SM, Cleves MA, Simmons CJ, Flynn B. Perineal approach for artificial urinary sphincter implantation appears to control male stress incontinence better than the transscrotal approach. J Urol. 2008 Apr. 179(4):1475-9; discussion 1479. [Medline].

  10. Elliott DS, Boone TB. Combined stent and artificial urinary sphincter for management of severe recurrent bladder neck contracture and stress incontinence after prostatectomy: a long-term evaluation. J Urol. 2001 Feb. 165(2):413-5. [Medline].

  11. Yates DR, Phé V, Rouprêt M, Vaessen C, Parra J, Mozer P. Robot-assisted laparoscopic artificial urinary sphincter insertion in men with neurogenic stress urinary incontinence. BJU Int. 2013 Jun. 111(7):1175-9. [Medline].

  12. Bryan DE, Mulcahy JJ, Simmons GR. Salvage procedure for infected noneroded artificial urinary sphincters. J Urol. 2002 Dec. 168(6):2464-6. [Medline].

  13. Elliott DS, Barrett DM, Gohma M, Boone TB. Does nocturnal deactivation of the artificial urinary sphincter lessen the risk of urethral atrophy?. Urology. 2001 Jun. 57(6):1051-4. [Medline].

  14. Kowalczyk JJ, Spicer DL, Mulcahy JJ. Long-term experience with the double-cuff AMS 800 artificial urinary sphincter. Urology. 1996 Jun. 47(6):895-7. [Medline].

  15. O'Connor RC, Lyon MB, Guralnick ML, Bales GT. Long-term follow-up of single versus double cuff artificial urinary sphincter insertion for the treatment of severe postprostatectomy stress urinary incontinence. Urology. 2008 Jan. 71(1):90-3. [Medline].

  16. Margreiter M, Farr A, Sharma V, Schauer I, Klingler HC. Urethral buttressing in patients undergoing artificial urinary sphincter surgery. J Urol. 2013 May. 189(5):1777-81. [Medline].

  17. Diokno AC. Erosions of the artificial urinary sphincter: risk factors, outcomes and management. Nat Clin Pract Urol. 2006 Nov. 3(11):580-1. [Medline].

  18. Magera JS Jr, Elliott DS. Tandem transcorporal artificial urinary sphincter cuff salvage technique: surgical description and results. J Urol. 2007 Mar. 177(3):1015-9; discussion 1019-20. [Medline].

  19. Bates AS, Martin RM, Terry TR. Complications following artificial urinary sphincter placement after radical prostatectomy and radiotherapy: a meta-analysis. BJU Int. 2015 Oct. 116 (4):623-33. [Medline].

  20. Elliott DS, Barrett DM. Mayo Clinic long-term analysis of the functional durability of the AMS 800 artificial urinary sphincter: a review of 323 cases. J Urol. 1998 Apr. 159(4):1206-8. [Medline].

  21. Thomas K, Venn SN, Mundy AR. Outcome of the artificial urinary sphincter in female patients. J Urol. 2002 Apr. 167(4):1720-2. [Medline].

  22. Costa P, Poinas G, Ben Naoum K, Bouzoubaa K, Wagner L, Soustelle L, et al. Long-Term Results of Artificial Urinary Sphincter for Women with Type III Stress Urinary Incontinence. Eur Urol. 2012 Mar 16. [Medline].

  23. Herndon CD, Rink RC, Shaw MB, Simmons GR, Cain MP, Kaefer M. The Indiana experience with artificial urinary sphincters in children and young adults. J Urol. 2003 Feb. 169(2):650-4; discussion 654. [Medline].

  24. Catti M, Lortat-Jacob S, Morineau M, Lottman H. Artificial urinary sphincter in children -- voiding or emptying? An evaluation of functional results in 44 patients. J Urol. 2008. 180:690 - 3. [Medline].

  25. Barrett DM, Furlow WL. Incontinence, intermittent self-catheterization and the artificial genitourinary sphincter. J Urol. 1984 Aug. 132(2):268-9. [Medline].

  26. Barrett DM, O'Sullivan DC, Malizia AA, Reiman HM, Abell-Aleff PC. Particle shedding and migration from silicone genitourinary prosthetic devices. J Urol. 1991 Aug. 146(2):319-22. [Medline].

  27. Choe JM. Freedom Regained: Female Urinary Incontinence Can Be Overcome. Columbus, Ohio: Anadem Publishing; 1999. 199-201.

  28. Choe JM, Staskin DR. Artificial urinary sphincter: evolution and development. J Long Term Eff Med Implants. 1997. 7(1):75-100. [Medline].

  29. DiMarco DS, Elliott DS. Tandem cuff artificial urinary sphincter as a salvage procedure following failed primary sphincter placement for the treatment of post-prostatectomy incontinence. J Urol. 2003 Oct. 170(4 Pt 1):1252-4. [Medline].

  30. Diokno AC, Hollander JB, Alderson TP. Artificial urinary sphincter for recurrent female urinary incontinence: indications and results. J Urol. 1987 Oct. 138(4):778-80. [Medline].

  31. Fishman IJ, Shabsigh R, Scott FB. Experience with the artificial urinary sphincter model AS800 in 148 patients. J Urol. 1989 Feb. 141(2):307-10. [Medline].

  32. Furlow WL, Barrett DM. Recurrent or persistent urinary incontinence in patients with the artificial urinary sphincter: diagnostic considerations and management. J Urol. 1985 May. 133(5):792-5. [Medline].

  33. Goldwasser B, Furlow WL, Barrett DM. The model AS 800 artificial urinary sphincter: Mayo Clinic experience. J Urol. 1987 Apr. 137(4):668-71. [Medline].

  34. Gundian JC, Barrett DM, Parulkar BG. Mayo Clinic experience with use of the AMS800 artificial urinary sphincter for urinary incontinence following radical prostatectomy. J Urol. 1989 Dec. 142(6):1459-61. [Medline].

  35. Heitz M, Olianas R, Schreiter F. [Therapy of female urinary incontinence with the AMS 800 artificial sphincter. Indications, outcome, complications and risk factors]. Urologe A. 1997 Sep. 36(5):426-31. [Medline].

  36. Kreder KJ, Webster GD. Evaluation and management of incontinence after implantation of the artificial urinary sphincter. Urol Clin North Am. 1991 May. 18(2):375-81. [Medline].

  37. Leo ME, Barrett DM. Success of the narrow-backed cuff design of the AMS800 artificial urinary sphincter: analysis of 144 patients. J Urol. 1993 Nov. 150(5 Pt 1):1412-4. [Medline].

  38. Light JK, Reynolds JC. Impact of the new cuff design on reliability of the AS800 artificial urinary sphincter. J Urol. 1992 Mar. 147(3):609-11. [Medline].

  39. Light JK, Scott FB. The artificial urinary sphincter in children. Br J Urol. 1984 Feb. 56(1):54-7. [Medline].

  40. Marques Queimadelos A, Abascal Garcia R, Muruamendiaraz Fernandez V. [Artificial sphincter implantation in women with urinary incontinence using a combined abdomino-vaginal approach]. Arch Esp Urol. 1999 Oct. 52(8):877-80. [Medline].

  41. Martins FE, Boyd SD. Artificial urinary sphincter in patients following major pelvic surgery and/or radiotherapy: are they less favorable candidates?. J Urol. 1995 Apr. 153(4):1188-93. [Medline].

  42. Meulen T, Zambon JV, Janknegt RA. Treatment of anastomotic strictures and urinary incontinence after radical prostatectomy with urolume wallstent and AMS 800 artificial sphincter. J Endourol. 1999 Sep. 13(7):517-20. [Medline].

  43. Montague DK, Angermeier KW. Artificial urinary sphincter troubleshooting. Urology. 2001 Nov. 58(5):779-82. [Medline].

  44. O'Connor RC, Gerber GS, Avila D, Chen AA, Bales GT. Comparison of outcomes after single or DOUBLE-CUFF artificial urinary sphincter insertion. Urology. 2003 Oct. 62(4):723-6. [Medline].

  45. Petero VG Jr, Diokno AC. Comparison of the long-term outcomes between incontinent men and women treated with artificial urinary sphincter. J Urol. 2006 Feb. 175(2):605-9. [Medline].

  46. Raj GV, Peterson AC, Toh KL, Webster GD. Outcomes following revisions and secondary implantation of the artificial urinary sphincter. J Urol. 2005 Apr. 173(4):1242-5. [Medline].

  47. Rose SC, Hansen ME, Webster GD. Artificial urinary sphincters: plain radiography of malfunction and complications. Radiology. 1988 Aug. 168(2):403-8. [Medline].

  48. Saffarian A, Walsh K, Walsh IK, Stone AR. Urethral atrophy after artificial urinary sphincter placement: is cuff downsizing effective?. J Urol. 2003 Feb. 169(2):567-9. [Medline].

  49. Salisz JA, Diokno AC. The management of injuries to the urethra, bladder or vagina encountered during difficult placement of the artificial urinary sphincter in the female patient. J Urol. 1992 Nov. 148(5):1528-30. [Medline].

  50. Scott FB, Bradley WE, Timm GW. Treatment of urinary incontinence by implantable prosthetic sphincter. Urology. 1973 Mar. 1(3):252-9. [Medline].

  51. Shires GT, Canizaro PC. Fluid, Electrolyte, and Nutritional Management of the Surgical Patient. Schwartz SI, Lillehei RC, Shires GT, et al, eds. Principles of Surgery. 2nd ed. New York, NY: McGraw-Hill; 1974. 65.

  52. Smith JJ, Barrett DM. Implantation of the artificial genitourinary sphincter. Walsh PC, ed. Campbell's Urology. 8th ed. Philadelphia, Pa: Elsevier Science; 2002. 1187-94.

  53. Tse V, Stone AR. Incontinence after prostatectomy: the artificial urinary sphincter. BJU Int. 2003 Dec. 92(9):886-9. [Medline].

  54. Webster GD, Guralnick ML. The neurourologic evaluation. Walsh PC, ed. Campbell's Urology. 8th ed. Philadelphia, Pa: Elsevier Science; 2002. 900-30.

  55. Webster GD, Sherman ND. Management of male incontinence following artificial urinary sphincter failure. Curr Opin Urol. 2005 Nov. 15(6):386-90. [Medline].

  56. Webster GD, Sihelnik SA. Troubleshooting the malfunctioning Scott artificial urinary sphincter. J Urol. 1984 Feb. 131(2):269-72. [Medline].

Previous
Next
 
The artificial urinary sphincter (AMS 800) is composed of a pressure-balloon reservoir, an inflate-deflate cuff, and a miniature control pump.
The patient is placed in the dorsolithotomy position. A perineal incision has been made below the scrotum. The Colles fascia is being dissected off.
The bulbocavernosus muscle has been dissected off. The bulbar urethra is exposed.
The right-angle clamp is passed behind the bulbar urethra.
The measuring tape is passed around the bulbar urethra. The bulbar urethra measures 4.5 cm; thus, a 4.5-cm cuff is chosen for implantation.
The artificial urinary sphincter cuff is passed—the tab end first—around the urethra. The cuff is snapped into place.
The tab of the artificial urinary sphincter cuff is rotated dorsally.
The cuff is seated in an excellent position. The tubing from the cuff is passed up to the suprapubic wound, where it is connected to the control pump.
The perineal incision is being closed. The Colles fascia is closed. The skin is closed next.
The balloon reservoir has been placed into the subrectus space, and the control pump has been inserted into the right hemiscrotum because the patient is right-handed. The cuff, pump, and reservoir are all connected.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.